Pathway for Pre-Entrepreneurship of Inserm Transfert
Thinking about Entrepreneurship: Pathway for Pre-Entrepreneurship of Inserm Transfert
Company creation is one of the way for value creation based on results obtained from academic or clinical research. It should always be considered within the range of other possible approaches (such as licensing to existing companies for instance), keeping in mind an optimized return to co-owners and inventors is sought as well as economic and societal value creation.
Many researchers wish to know how to create a startup and seek advice to do so in the best way.
Inserm Transfert has launched in 2017 this Pathway for Pre-Entrepreneurship to support researchers/inventors that aspire to become involved in entrepreneurship and to help them become « Enlighted founders (“Fondateurs Eclairés”) aware of what it implies to create a company.
The objective is to offer them a tailored assistance in their project of startup creation as earlier as possible by helping them to structure their project around 6 factors that we believe are key for success:
A solid team ready to work together in the long term;
A differentiating innovation (technology or product) validated by robust pre/maturation, with reliable solid and reproducible research results, and up to “due diligence” standards of companies or investors.
The objective is to create solid and long-term startups able to face a worldwide competition, to fundraise and to bring products into clinical phases.
This Pathway for Pre-entrepreneurship is based on the strong expertise of Inserm Transfert teams in entrepreneurship, intellectual property and product development and on the complementarities of its partners in company creation (incubators, investors, etc.).
There are two major steps in this pathway:
The objective of Pre-Entrepreneurship Meetings is to gather scientists, willing to create their startup, and experts. Each researcher/inventor has 2 hours at his disposal to introduce his project and exchange with a panel of experts around different aspects of entrepreneurship (team, technological innovation, protection and legal environment, market access and business model strategy in coherence with financial aspects) without any stakes on the licensing agreement or a possible fundraising.
A possibility to be certified by the HHSF consortium with the French Tech Seed label to get a co-investment from BPIfrance in convertible bonds during the first investments post creation.
An entrepreneurship project? Contact us to know more.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
Since Monday 11th of May, Inserm Transfert plans a progressive return on site according to the evolution of the sanitary situation and the recommendations of the government. Inserm Transfert has taken all the necessary actions to ensure a service continuation while protecting its employees. All our employees are working from home and are still available to help you out via e-mail, phone or videoconference.